UPDATE June 9, 2016 The Senate Appropriations Committee voted to approve its FY17 Labor-HHS Appropriations bill earlier today, with only one senator, Bill Cassidy (R-LA), voting against the bill. Funding for the Centers for Disease Control’s Prostate Cancer activities program was restored!!! Thanks to all of Malecare’s Patient Advocacy Leaders and ALL of You who sent emails and made phone calls to the Senate Appropriations Committee
The USA federal Fiscal Year (FY) 2017 Budget eliminates funding ($13.2 million) for the entire Prostate Cancer program at the Centers for Disease Control (CDC). Malecare asks for your advocacy for restoring that funding. Click here to help out http://malecare.org/advocacy/cdc-prostate-cancer-2017/
The CDC has produced dynamic prostate cancer research, particularly focused on underserved populations such as African American men, and on improving doctor – patient communication. However, you should also be aware that the CDC, just like other federal agencies, follow the prostate cancer screening recommendations set forth by the U.S. Preventive Services Task Force, which recommends against PSA based screening for men who do not have symptoms.
Malecare feels that the benefits of the CDC Prostate Cancer program are worthy of continued funding.
Representatives hear from very few prostate cancer survivors and family members so your letter will be surprisingly powerful.
Please click here to tell Congress, Prostate Cancer Research Funding is not negotiable!